Related Tags >> FDA Pliva Generics Plan B

Barr Pharmaceuticals News

Most Popular Barr Pharmaceuticals Story

DEALS: J&J buys Pfizer's OTC division for $16.6B

July 5, 2006 — 7:01pm ET

J&J buys Pfizer's OTC division for $16.6B

Read more...

Barr Pharmaceuticals Press Releases

Latest Headlines

Teva and Barr - Top 10 deals of 2008
January 13, 2009
Itero raises $21M; Immunicon files for Chapter 11; AVI cuts staff;
June 11, 2008
C&L: Bethune tapped as interim Zila CEO
April 2, 2008
C&L: Engle takes helm at XOMA
August 8, 2007
SPOTLIGHT: Bisaro handed reigns at Watson
August 2, 2007
ALSO NOTED: Ariad selling shares; Indevus gains milestone; Barr closing on Pliva; and much more...
October 19, 2006
Barr gains majority of Pliva shares
October 10, 2006
ALSO NOTED: Barr raises bid on Pliva; Synta touts new data; regulators question Factive rashes;and much more...
September 10, 2006
ALSO NOTED: Daiichi Sankyo invests in venture fund; ImaRx sets IPO terms; and much more...
September 7, 2006
Barr takes cautious approach in marketing Plan B
August 24, 2006
FDA clears Plan B, ending FDA confirmation fight
August 23, 2006
ALSO NOTED: Xyotax trial indicates efficacy; Wyeth encouraged by FDA meeting cancellation;and much more...
August 22, 2006
Editor's Corner
August 20, 2006
FEATURE: A Step in the Right Direction?
August 17, 2006
Generic drug makers line up for biogenerics
August 15, 2006
FDA clears way for Plan B to go OTC
August 8, 2006
FDA indicates it may allow Plan B to go OTC
July 31, 2006
ALSO NOTED: Ono to start cancer trials; Ligand CEO steps down; and much more...
July 31, 2006
ALSO NOTED: TransPharma raises $18M; Biogen Idec, Elan re-release Tysabri; and much more...
July 23, 2006
DEALS: J&J buys Pfizer's OTC division for $16.6B
July 5, 2006

Paid Research Reports

More Research Reports >>